Effect of somatostatin analog on high-fat diet-induced metabolic syndrome: Involvement of reactive oxygen species

Peptides

Volumn 31, Issue 4, 2010, Pages 625-629

  Li, Wu ^a   Shi, Yong Hui ^a   Yang, Rui li ^a   Cui, Jue ^a   Xiao, Ying ^a   Wang, Bin ^a   Le, Guo Wei ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

High fat diet; Metabolic syndrome; Reactive oxygen species; Somatostatin

Indexed keywords

BILE ACID; GLUCOSE; GLUTATHIONE; GLUTATHIONE DISULFIDE; INSULIN; OCTREOTIDE; REACTIVE OXYGEN METABOLITE; SOMATOSTATIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID DIET; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SOMATOSTATIN BLOOD LEVEL; STOMACH PH; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FATS; EATING; GASTROINTESTINAL AGENTS; GASTROINTESTINAL TRACT; GLUTATHIONE; HUMANS; LIPIDS; MALE; MALONDIALDEHYDE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; OCTREOTIDE; ORGAN SIZE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SOMATOSTATIN;

MUS;

EID: 77649238849     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.11.008     Document Type: Article

References (37)

1. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23 (2006) 469-480
2. Aljada A., Mohanty P., Ghanim H., Abdo T., Tripathy D., Chaudhuri A., et al. Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr 79 (2004) 682-690
3. Ando K., and Fujita T. Metabolic syndrome and oxidative stress. Free Radic Biol Med 47 (2009) 213-218
4. Aude Y.W., Mego P., and Mehta J.L. Metabolic syndrome: dietary interventions. Curr Opin Cardiol 19 (2004) 473-479
5. Austin M.A. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11 (1991) 2-14
6. Bae J.H., Bassenge E., Kim K.B., Kim Y.N., Kim K.S., Lee H.J., et al. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 155 2 (2001) 517-523
7. Boehm B.O. The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetes. Expert Opin Investig Drugs 12 (2003) 1501-1509
8. Bowen P.E., and Borthakur G. Postprandial lipid oxidation and cardiovascular disease risk. Curr Atheroscler Rep 6 (2004) 477-484
9. Cardona F., Túnez I., Tasset I., Garrido-Sánchez L., Collantes E., and Tinahones F.J. Circulating antioxidant defences are decreased in healthy people after a high-fat meal. Br J Nutr 100 2 (2008) 312-316
10. Devaraj S., Wang-Polagruto J., Polagruto J., Keen C.L., and Jialal I. High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism 57 (2008) 867-870
11. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23 (2002) 599-622
12. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114 (2004) 1752-1761
13. Garg A. Regional adiposity and insulin resistance. J Clin Endocrinol Metab 89 (2004) 4206-4210
14. Grattagliano I., Palmieri V.O., Portincasa P., Moschetta A., and Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem 19 (2008) 491-504
15. Hansen J.B., Arkhammar P.O., Bodvarsdottir T.B., and Wahl P. Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders. Curr Med Chem 11 (2004) 1595-1615
16. Hauge-Evans A., King A., Carmignac D., Richardson C., Robinson I., Low M., et al. Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 58 (2009) 403-411
17. Houstis N., Rosen E.D., and Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440 (2006) 944-948
18. Jacob C., Giles G.I., Giles N.M., and Sies H. Sulfur and selenium: the role of oxidation state in protein structure and function. Angew Chem Int Ed Engl 42 (2003) 4742-4758
19. Janson E.T., and Oberg K. Somatostatin receptor ligands and their use in the treatment of endocrine disorders. Curr Pharm Des 5 (1999) 693-705
20. Kopprasch S., Kohl M., and Graessler J. Different effects of exogenous horseradish peroxidase on luminol-amplified chemiluminescence induced by soluble and particulate stimuli in human neutrophils. J Biolumin Chemilumin 13 (1998) 267-271
21. Krejs G.J., Browne R., and Raskin P. Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes. Gastroenterology 78 (1980) 26-31
22. Lustig R.H., Hinds P.S., Ringwald-Smith K., Christensen R.K., Kaste S.C., Schreiber R.E., et al. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88 (2003) 2586-2592
23. Matsuzawa-Nagata N., Takamura T., Ando H., Nakamura S., Kurita S., Misu H., et al. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 57 (2008) 1071-1077
24. Minehira K., and Tappy L. Dietary and lifestyle interventions in the management of the metabolic syndrome: present status and future perspective. Eur J Clin Nutr 56 (2002) 7 pp. following 1262
25. Mohanty P., Ghanim H., Hamouda W., Aljada A., Garg R., and Dandona P. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 75 (2002) 767-772
26. Moller N., Petrany G., Cassidy D., Sheldon W.L., Johnston D.G., and Laker M.F. Effects of the somatostatin analogue SMS 201-995 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man. Clin Sci (Lond) 75 (1988) 345-350
27. Nishikawa T., and Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 9 (2007) 343-353
28. Ohara Y., Peterson T.E., and Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91 (1993) 2546-2551
29. Patel Y. Somatostatin and its receptor family. Front Neuroendocrinol 20 (1999) 157-198
30. Roberts C.K., Barnard R.J., Sindhu R.K., Jurczak M., Ehdaie A., and Vaziri N.D. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 55 (2006) 928-934
31. Scalera G., and Tarozzi G. Somatostatin administration modifies food intake, body weight, and gut motility in rat. Peptides 19 (1998) 991-997
32. Schafer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30 (2001) 1191-1212
33. Senft A.P., Dalton T.P., and Shertzer H.G. Determining glutathione and glutathione disulfide using the fluorescence probe o-phthalaldehyde. Anal Biochem 280 (2000) 80-86
34. Slater E.E., Katzen H.M., Nutt R.F., Saperstein R., and Steelman S.L. The effects of somatostatin and selected analogs on lipid absorption in animals. Adv Exp Med Biol 188 (1985) 355-368
35. Taniguchi A., Nakai Y., Sakai M., Yoshii S., Hamanaka D., Hatae Y., et al. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Metabolism 51 (2002) 544-548
36. Temel R.E., and Rudel L.L. Diet effects on atherosclerosis in mice. Curr Drug Targets 8 (2007) 1150-1160
37. Yang R.L., Li W., Shi Y.H., and Le G.W. Lipoic acid prevents high-fat diet-induced dyslipidemia and oxidative stress: a microarray analysis. Nutrition 24 (2008) 582-588